about
Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and backReport from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunityNew genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityEvolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?Recent Advances in Application of Pharmacogenomics for BiotherapeuticsMechanism of isoniazid‐induced hepatotoxicity: then and nowPharmacogenomics of off-target adverse drug reactions.Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis.Immediate and non-immediate allergic reactions to amoxicillin present a diagnostic dilemma: a case series.The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015.Human biology-based drug safety evaluation: scientific rationale, current status and future challenges.Pharmacology-based toxicity assessment: towards quantitative risk prediction in humans.Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.Recent advances in the understanding of severe cutaneous adverse reactions.Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.Novel Concepts for Drug Hypersensitivity Based on the Use of Long-Time Scale Molecular Dynamic Simulation.HLAs: Key regulators of T-cell-mediated drug hypersensitivity.Pharmacogenetics: a general review on progress to date.Structure-based selection of human metabolite binding P4 pocket of DRB1*15:01 and DRB1*15:03, with implications for multiple sclerosis.Berberine Attenuates Inflammation Associated with Delayed-Type Hypersensitivity via Suppressing Th1 Response and Inhibiting Apoptosis.A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.Drug-Induced Hypersensitivity Syndrome: A Clinical, Radiologic, and Histologic Mimic of Lymphoma
P2860
Q26784638-E3A922A8-A639-4CF9-ACAA-C6BCC1355A6DQ26800964-6FB54B83-7B33-4CB1-A248-53997E8426A7Q26800973-E7BFFCE8-33A8-4219-A760-246D0077BA69Q26800976-E4E511AB-219D-44C8-BFE7-980E500F4F3AQ26800980-F712E34A-EAD7-437C-A897-1F20CCBEF46EQ27335110-39721587-A604-4149-96C8-E4C77B32BD0EQ29247996-20A9AF0F-458C-42DB-9915-5638D3A1C0ECQ29248263-69EE4F7B-7466-4258-83D6-3D8F3416F104Q30400366-7B9DFABA-43F5-4C49-AFAA-F3815049DFD5Q33703420-0021F3B2-AC22-4C82-BD5E-7AFFC3C75E74Q36476299-F07979F6-904A-4F4C-AE6F-870D87F69132Q38707503-B1DC47BE-1BC9-479B-82D2-3B865CF79B3CQ38763000-73816A7D-B4C4-40A0-BADC-96C2A026FFB6Q38771635-BB806ADD-A4A7-40CD-B808-243E13D4A639Q38860427-5E4728F8-5CF1-4258-B5F1-AC562A793324Q38931289-E46BEACC-84F2-45F4-B429-021E17D69408Q39037278-4E2E6AEE-EA1B-40F8-82E3-7DAF26184153Q39110729-63DC4A4F-3B4A-491C-842C-52E7717F3C19Q39291741-B2F57CF3-BCF3-4F6C-A255-EF973C5F84D8Q41876196-B84E0E7B-1991-43B9-A50C-3022DC3729E9Q47320133-8BFC3B83-90A0-41FC-B3FA-8E9F4316AA9DQ47776901-E3006025-E9FF-434C-B445-555730748A05Q48044178-36C76FA9-C502-4A3C-9E28-5D507D294DC0Q51334170-7C15217D-855C-40A0-9F43-ADCE08C3C412Q54204422-9C84AA8E-57BB-46BB-A982-2885EF907F59Q58699205-AE7F5430-334A-4AD5-BCCB-883B77785DC0
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
T cell-mediated hypersensitivity reactions to drugs
@ast
T cell-mediated hypersensitivity reactions to drugs
@en
T cell-mediated hypersensitivity reactions to drugs
@nl
type
label
T cell-mediated hypersensitivity reactions to drugs
@ast
T cell-mediated hypersensitivity reactions to drugs
@en
T cell-mediated hypersensitivity reactions to drugs
@nl
prefLabel
T cell-mediated hypersensitivity reactions to drugs
@ast
T cell-mediated hypersensitivity reactions to drugs
@en
T cell-mediated hypersensitivity reactions to drugs
@nl
P2093
P2860
P50
P1476
T cell-mediated hypersensitivity reactions to drugs
@en
P2093
Bjoern Peters
David Ostrov
Imir Metushi
Simon Mallal
P2860
P304
P356
10.1146/ANNUREV-MED-050913-022745
P577
2014-10-27T00:00:00Z